Gardner Lewis Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-21,385
Closed -$812K – 79
2018
Q4
$812K Buy
+21,385
New +$755K 0.07% 64

Other funds holding TNDM

Gardner Lewis Asset Management's TNDM Position: Q1 2019 in Review

Gardner Lewis Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2019, closing a stake of 21,385 shares — an estimated $812K sold.

Gardner Lewis Asset Management first reported a position in TNDM in Q4 2018 and held it in 1 quarter. The position peaked at $812K in Q4 2018. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

  • Gardner Lewis Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2019 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 21,385 Tandem Diabetes Care shares in Q1 2019, an estimated $812K.
  • Gardner Lewis Asset Management first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Tandem Diabetes Care position peaked at $812K in Q4 2018.
  • 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2019, filed 15 May 2019.